Table 1.
Lipid profiles with time on various treatments
| Date | TC | HDL-C | LDL-C | TG | Remarks |
|---|---|---|---|---|---|
| December 2011 | 5.2 | 1.0 | 3.0 | 0.9 | Given fenofibrate 160 mg daily |
| January 2012 | 5.7 | 1.0 | 3.2 | 1.1 | Remained on above |
| June 2012 | 6.0 | 1.4 | 3.1 | 1.3 | Given niacin 100 mg daily |
| February 2013 | 6.1 | 0.9 | – | 1.3 | Remained on above |
| November | 6.1 | 1.2 | 4.2 | 0.9 | Given rosuvastatin |
| 2013 | and CoE Q10 | ||||
| February 2014 | 3.7 | 1.0 | 1.7 | 1.4 | Remained on above |
| May 2014 | 3.8 | 1.0 | 2.0 | 0.7 | On above, no muscle/memory issue |
Notes: All values are in units of mmol/L. Fenofibrate gave mild muscle discomfort that was later followed by vertigo and ataxia. Niacin gave no side effects but did not improve lipid profile. Rosuvastatin and CoE Q10 normalized lipid profile and did not cause any side effects.
Abbreviations: TC, total cholesterol; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; TG, triglyceride; CoE Q10, co-enzyme Q10.